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http:WHAT THIS PAPER ADDS
This study gives an overview of all genetic studies of abdominal aortic aneurysm (AAA) risk to date, critically
examines the role of study design in the reporting of false associations, and makes recommendations about
future studies of AAA susceptibility.Objective/Background: Many associations between abdominal aortic aneurysm (AAA) and genetic
polymorphisms have been reported. It is unclear which are genuine and which may be caused by type 1 errors,
biases, and ﬂexible study design. The objectives of the study were to identify associations supported by current
evidence and to investigate the effect of study design on reporting associations.
Methods: Data sources were MEDLINE, Embase, and Web of Science. Reports were dual-reviewed for relevance
and inclusion against predeﬁned criteria (studies of genetic polymorphisms and AAA risk). Study characteristics
and data were extracted using an agreed tool and reports assessed for quality. Heterogeneity was assessed using
I2 and ﬁxed- and random-effects meta-analyses were conducted for variants that were reported at least twice, if
any had reported an association. Strength of evidence was assessed using a standard guideline.
Results: Searches identiﬁed 467 unique articles, of which 97 were included. Of 97 studies, 63 reported at least
one association. Of 92 studies that conducted multiple tests, only 27% corrected their analyses. In total, 263
genes were investigated, and associations were reported in polymorphisms in 87 genes. Associations in
CDKN2BAS, SORT1, LRP1, IL6R, MMP3, AGTR1, ACE, and APOA1 were supported by meta-analyses.
Conclusion: Uncorrected multiple testing and ﬂexible study design (particularly testing many inheritance models
and subgroups, and failure to check for HardyeWeinberg equilibrium) contributed to apparently false
associations being reported. Heterogeneity, possibly due to the case mix, geographical, temporal, and
environmental variation between different studies, was evident. Polymorphisms in nine genes had strong or
moderate support on the basis of the literature at this time. Suggestions are made for improving AAA genetics
study design and conduct.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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It has been claimed that most published research ﬁndings
are false and that studies of complex genetic diseases are
especially prone to reporting false associations.1 Abdominal
aortic aneurysms (AAA) occur in Mendelian disorders,2 but
are usually multifactorial. Understanding AAA pathogenesis
might lead to new treatments or preventive measures. No
meaningful personalised genetic risk prediction has been
realised for AAA.3
Table 1. Databases and time periods searched.
Database Date range
MEDLINE 1946eAugust, week 1, 2014
Embase 1980e2014, week 33
Web of Science All yearse25 August 2014
Abdominal Aortic Aneurysm Genetic Associations 65AAA is usually deﬁned as infrarenal aortic diameter
30 mm.4 Using alternative deﬁnitions (infrarenal aortic
diameter:suprarenal aortic diameter ratio, or comparison to
predicted diameter) has striking effects on prevalence.5
Participants may be recruited from screening programmes
or surgical departments, affecting case mix. The prevalence
of old age, tobacco use, and medication use has changed
over time and differs between locations, so geneeenvi-
ronment interactions could affect results.6e8
Ioannidis claimed that six factors increased the likelihood
of research ﬁndings being false: small study size; small ef-
fect size; multiple testing; ﬂexible study design; ﬁnancial or
other interests; and the “hotness” of the ﬁeld.1 The
STrengthening the REporting of Genetic Association Studies
(STREGA) guidance aims to make reports consistent and
transparent,9 but there is variation in the analytic and sta-
tistical methods used. This study aimed to identify gene
associations supported by evidence and to investigate the
role of study design in reporting associations.
METHODS
Search strategy
Databases were searched using Medical Subject Heading
terms (Table 1; Supplementary Methods) on 25 August
2014. The MEDLINE search was simply “Aortic Aneurysm,
Abdominal/ge [Genetics]”, limited to human studies. The
National Institutes of Health association database, refer-
ences, and relevant journals were also searched.
Inclusion criteria
The study population included cases with AAA (infrarenal
aorta >30 mm, infrarenal/suprarenal aortic ratio  1.5,
surgical repair, or ruptured AAA); controls were untested
individuals, tested controls, or hospital controls. The study
investigated germline genomic polymorphisms. The study
compared disease risk in individuals with or without poly-
morphisms, or odds of exposure in individuals with/without
AAA in caseecontrol, cross-sectional, or cohort studies. The
study outcome was the presence or absence of AAA.
Exclusion criteria
Studies with single-disease controls (e.g., ischaemic heart
disease), studies of somatic mutations, linkage studies, and
studies of AAA growth or size were excluded.
Study selection and data abstraction
Two authors independently assessed titles and abstracts for
relevance and full reports for inclusion. Two authors inde-
pendently extracted quality and genotype/risk data forpolymorphisms reported twice or more with an association
reported at least once. Additional characteristics were
abstracted by one authorData analysis
Median study size was calculated for each year. Odds ratios
(OR) for heterozygotes and homozygotes were calculated.
Where genotype counts were not available, inheritance
models from original reports were used. Additive model
analyses were conducted using binary logistic regression in
IBM SPSS Statistics v19.0 (IBM Corp., Armonk, NY, USA),
with genotypes coded as 0, 1, or 2. Original CRP data from
Badger et al. were reanalysed to allow meta-analysis with
the results of Saratzis et al.10,11 HardyeWeinberg equilib-
rium (HWE) deviation was assessed by Haldane’s exact test
in R. Sensitivity analyses excluded studies with HWE devi-
ation (p < .05). A single nucleotide polymorphism (SNP)
Annotation and Proxy Search (Broad Institute, Cambridge,
MA, USA) identiﬁed markers with r2 > 0.9. Where study
data were published more than once (i.e., a study was
updated, or reported study populations overlapped), the
selection of the report for inclusion was based on the
reporting of genotype counts/frequencies or risk in prefer-
ence to allelic or speciﬁc inheritance models. If the mode of
reporting was the same, then the larger study was included.
Heterogeneity index (I2) and Cochrane’s Q were esti-
mated using meta in R. I2 >50% was large, and 25e50%
moderate.12 Fixed- and random-effects inverse variance-
weighted meta-analysis was conducted using meta in R.
Signiﬁcance was p < .05 in ﬁxed-effects meta-analysis if I2
<25% or random effects meta-analysis if I2  25%.
RESULTS
Search results
Searches yielded 614 records. Ten were identiﬁed from
other sources. There were 477 unique records. Ninety-seven
were included (Fig. 1). Excluded studies are listed in
Supplementary Table 1.
Study types and reports of associations
There were 91 candidate gene studies, four genome-wide
association studies (GWAS), and two genetic risk score
(GRS) studies (Table 2). Fifty-six candidate studies, both GRS
and all GWAS reported associations.
Study size and frequency
Median study size for a candidate gene or GRS study was
710 participants (range 91e83,024). Study size and fre-
quency of reports increased over time (Fig. 2). There was a
median of three reports per year between 1994 and 25
August 2014.
Study quality
Quality indicators and detailed characteristics are shown in
Table 2 and Supplementary Table 2, respectively. Sixty-two
Figure 1. Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) ﬂowchart for systematic review. Note.
AAA ¼ abdominal aortic aneurysm.
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66 D.T. Bradley et al.studies (64%) reported an association. Ninety-two studies
reported multiple tests, and 25 (27%) adjusted analyses for
this.Et
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In total, 263 genes were investigated (Supplementary
Table 3), with 87 associated at least once. The median
study size for reports that claimed an association was 811,
and that of those that did not was 710 (independent
samples ManneWhitney U standardised test statistic ¼ .10;
p ¼ .92).as
es
)
C
o
n
tr
o
ls
(n
)
2
79
32
24
5
5
34
25
15
3
4
51
7
17
4
8
41
0
90
16
3
24
11
2
02
11
8
0
61
31
10
6
00
10
0
14
20
3
9
23
7
0
17
2
9
22
5Selection of polymorphisms for meta-analysis
We identiﬁed genes that featured in at least two studies
and that had at least one association with sufﬁcient data
(Supplementary Table 3; Supplementary Table 4).Ta
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9Results of meta-analyses
Meta-analyses are summarised and shown in full in Table 3
and Supplementary Table 5, respectively. Associations be-
tween AAA and 9p21 rs10757278, SORT1 rs599839, LRP1
rs1466535, MMP3 rs3025058, AGTR1 rs5186, ACE
rs4646994, and APOA1 rs964184 were supported. CRP
rs3091244 lost signiﬁcance in sensitivity analysis. MMP2
rs243865 was associated but one of two studies deviated
from HWE. Six were supported by strong evidence, three by
moderate evidence, and 25 had weak evidence (Table 4).
Fatini46 2005 250 250 Yes No Tested No Yes Yes No Cand Yes
Fatini47 2005 250 250 Yes No Tested No Yes Yes No Cand Yes
Jones48 2005 428 282 No No Untested No Yes Yes No Cand No
Ogata49 2005 387 425 Yes Yes Untested No Yes Yes No Cand Yes
Schulz50 2005 133 910 Yes No Untested No No Yes No Cand No
Strauss51 2005 106 97 No No Untested No Yes Yes No Cand Yes
Ferrara52 2006 88 44 No No NR No No Yes Yes Cand Yes
Hinterseher53 2006 51 48 Yes No Untested No Yes Yes No Cand No
Ogata54 2006 387 426 Yes No Untested No No Yes Yes Cand Yes
Armani55 2007 146 156 No No Untested No No Yes No Cand No
Badger56 2007 241 1000 No No Untested No Yes Yes Yes Cand No
Bown57 2007 389 404 Partial No Tested No Yes Yes No Cand Yes
Deguara58 2007 405 405 Yes No Untested No No Yes No Cand Yes
Golledge59 2007 689 3538 No No Tested Yes Yes Yes Yes Cand No
Hinterseher60 2007 146 133 Yes No Untested No Yes Yes No Cand No
Peeters61 2007 88 88 No No Tested No No No NA Cand No
Waliszewski62 2007 112 50 Yes No Untested No No Yes No Cand Yes
Bown63 2008 899 815 Yes No Tested No Yes Yes No Cand Yes
Giusti64 2008 423 423 No No Tested No Yes Yes Yes Cand Yes
Gotting65 2008 129 129 No No Untested No Yes Yes Yes Cand Yes
Helgadottir15 2008 2836 16,732 Partial No Mixed No Yes Yes No Cand Yes
Hinterseher66 2008 50 41 Partial No Untested No Yes Yes No Cand Yes
Jones67 2008 1226 1723 Partial No Mixed No Yes Yes No Cand Yes
Smallwood68 2008 677 656 No No Tested Yes Yes Yes No Cand Yes
Smallwood69 2008 678 659 No No Tested Yes Yes Yes No Cand No
Badger70 2009 230 279 No No Tested No No Yes No Cand No
Badger10 2009 248 400 No No Tested No No No NA Cand No
Elmore71,72 2009 950 1146 No No Mixed No No Yes No GWAS Yes
Golledge73 2009 1294 1460 No No Tested Yes Yes Yes Yes Cand No
Jones74 2009 567 552 Yes NR Tested No No Yes No Cand No
Korcz75 2009 133 152 Yes No Tested No Yes Yes No Cand No
Lucarini76 2009 201 252 No No Tested No Yes Yes No Cand Yes
Sandford77 2009 285 273 Yes No Tested No No Yes No Cand No
Smallwood78 2009 678 659 No No Tested Yes Yes Yes Yes Cand Yes
Thompson79 2009 741 1366 No No Partial No No Yes No Cand Yes
Atli80 2010 61 62 No No Tested No No Yes No Cand Yes
Baas81 2010 736 1024 No No Mixed Yes Yes Yes Yes Cand No
Baas82 2010 736 1024 No No Mixed Yes Yes Yes Yes Cand Yes
Baas83 2010 736 1024 No No Mixed Yes Yes Yes Yes Cand No
Badger84 2010 230 278 Yes No Tested No Yes Yes No Cand No
Biros85 2010 513 2858 No No Tested No No Yes No Cand Yes
Golledge86 2010 640 1071 No No Tested Yes Yes Yes Yes Cand No
Gretarsdottir13 2010 4559 37,954 Partial No Mixed No No Yes Yes GWAS Yes
Moran87 2010 689 3538 No No Tested Yes Yes Yes No Cand Yes
Obukofe88 2010 1155 996 No No Tested No Yes Yes No Cand No
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Table 2-continued
First author Year Cases
(n)
Controls
(n)
Ethnicity
reported
Controlled for
ethnicity by
logistic
regression
Tested or
untested
controls
Genotyping
rate
reported
HWE
reported
Multiple
tests
Corrected for
multiple
testing
Study
type
Reported
association
Thompson89 2010 1890 3785 Yes No Mixed No Yes Yes No Cand No
Biros90 2011 834 795 No No Tested No Yes Yes No Cand Yes
Biros91 2011 1904 2616 No No Mixed No Yes Yes Yes Cand No
Bown14 2011 6228 49,182 No Partial Mixed No Yes Yes Yes GWAS Yes
Bradley92 2011 434 378 Yes No Tested Yes Yes Yes Yes Cand No
Hinterseher93 2011 874 899 No No NR No Yes Yes No Cand No
Katrancioglu94 2011 100 138 No No Tested No No Yes No Cand Yes
Lillvis95 2011 394 419 No No Untested No Yes Yes Yes Cand Yes
Roberts96 2011 1238 731 Yes No Tested Yes Yes Yes No Cand Yes
Bisoendial97 2012 613 707 No No Tested No Yes Yes No Cand No
Duellman98 2012 178 178 No No Tested No Yes Yes No Cand Yes
Helgadottir15 2012 4261 33,520 Partial No Mixed No Yes Yes Yes Cand Yes
Korcz99 2012 300 313 No No Tested No Yes Yes No Cand No
Oszajca100 2012 153 152 No No Untested No Yes Yes No Cand Yes
Saracini101 2012 423 423 No No Tested No Yes Yes Yes Cand Yes
Antoniou102 2013 65 89 Yes No Tested No No No NA Cand Yes
Bradley103 2013 5138 39,273 Partial Partial Mixed Yes Yes Yes Yes GWAS Yes
Galora104 2013 423 423 No No Tested No Yes Yes Yes Cand Yes
Gregorek105 2013 117 117 No No Tested No Yes Yes No Cand Yes
Harrison16 2013 4524 15,710 Partial No Mixed Yes Yes No NA Cand Yes
Jones17 2013 7048 75,976 Partial No Mixed Yes Yes Yes No Cand Yes
Tragante106 2013 651 2015 No No Untested Yes Yes Yes Yes GRS Yes
van ’t Hof107 2013 859 2089 Yes Yes Untested Yes Yes Yes No GRS Yes
Wong108 2013 318 3930 No No Tested No Yes Yes No Cand No
Bridge109 2014 602 490 Yes No Tested Yes Yes Yes No Cand Yes
Cao20 2014 463 463 Yes No Tested No Yes Yes No Cand Yes
Duellman110 2014 141 168 No No Tested Yes Yes Yes No Cand Yes
Galora111 2014 423 423 No No Untested No Yes Yes Yes Cand Yes
Li112 2014 316 306 No No Tested No Yes Yes No Cand Yes
Mikołajczyk-
Stecyna113
2014 128 180 No No Tested No Yes Yes No Cand Yes
Oszajca114 2014 153 152 No No Untested No No Yes No Cand Yes
Saratzis115 2015 797 793 Partial No Tested No Yes Yes No Cand No
Saratzis11 2014 722 753 Partial No Tested No Yes Yes No Cand Yes
Strauss116 2015 518 541 No No Untested No Yes Yes No Cand Yes
Wei117 2014 155 310 Yes No Tested Yes Yes Yes No Cand Yes
Note. HWE ¼ HardyeWeinberg equilibrium; NA ¼ not applicable; Cand ¼ candidate gene study; NR ¼ not reported; GWAS ¼ genome-wide association study; GRS ¼ genetic risk score.
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Table 3. Summary of meta-analyses.
Gene and polymorphism OR (
9p21 (CDKN2BAS) rs10757278 heterozygous (A/G) 1.28
9p21 (CDKN2BAS) rs10757278 homozygous (G/G) 1.55
ACE insertion/deletion (rs4646994) heterozygous (D/I) 0.90
ACE insertion/deletion (rs4646994) homozygous (I/I) 0.67
ACE insertion/deletion (rs4646994) heterozygous (D/I)a 0.85
ACE insertion/deletion (rs4646994) homozygous (I/I)a 0.67
AGTR1 rs5186 heterozygous (A/C) 1.25
AGTR1 rs5186 homozygous (C/C) 1.44
AGTR1 rs5186 allelic model (C allele) 1.19
APOA1 rs964184 additive (G allele) 1.20
APOB rs1367117 additive (A allele) 1.09
CCR5 rs333 heterozygous (WT/Del32) 1.34
CCR5 rs333 homozygous (Del32/Del32) 1.73
CRP rs3091244 heterozygous (group B) 1.58
CRP rs3091244 homozygous (group A) 2.16
CRP rs3091244 heterozygous (group B)a 1.25
CRP rs3091244 homozygous (group A)a 1.60
ELN rs2071307 heterozygous (A/G) 0.73
ELN rs2071307 homozygous (A/A) 0.90
HMOX1 GT(n) repeat heterozygous (GT(25)/GT(<25)) 1.21
HMOX1 GT(n) repeat homozygous (GT(<25)/GT(<25)) 1.03
IL10 rs1800896 heterozygous (G/A) 1.26
IL10 rs1800896 homozygous (A/A) 1.59
LRP1 rs1466535 heterozygous (C/T) 0.93
LRP1 rs1466535 homozygous (C/C) 0.85
LRP1 rs1466535 additive (C Allele) 1.09
LRP1 rs1466535 additive (C Allele)a 1.15
MMP2 rs243865 heterozygous (C/T) 0.87
MMP2 rs243865 homozygous (T/T) 0.65
MMP2 rs243865 dominant (C/T & T/T) 0.82
MMP3 rs3025058 heterozygous (6A/5A) 0.84
MMP3 rs3025058 homozygous (6A/6A) 0.61
MMP9 rs3918242 heterozygous (C/T) 1.05
MMP9 rs3918242 homozygous (T/T) 0.81
MMP9 rs3918242 heterozygous (C/T)a 1.08
MMP9 rs3918242 homozygous (T/T)a 0.93
MMP13 rs2252070 heterozygous (A/G) 1.08
MMP13 rs2252070 homozygous (G/G) 1.16
MTHFR1 rs1801133 heterozygous (C/T) 1.06
MTHFR1 rs1801133 homozygous (T/T) 1.06
MTHFR1 rs1801133 heterozygous (C/T)a 1.07
MTHFR1 rs1801133 homozygous (T/T)a 0.96
NOS3 rs1799983 heterozygous (G/T) 1.14
Figure 2. Study frequency and median study size, 1994e2014.
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Most studies reported associations, but only six were sup-
ported by strong evidence. Two were reported in genome-
wide studies (DAB2IP and LRP1),13,14 and four in candi-
date gene studies (9p21/CDKN2BAS, IL6R, LPA and
SORT1).15e18 There was moderate evidence for associations
with LDLR, MMP3, and AGTR1 polymorphisms. MMP3
rs3025058 was tentatively suggested, in 1999 in a small
study by Yoon et al.,19 to be a risk factor for AAA, although
it was not statistically signiﬁcant after correction for mul-
tiple testing. Subsequent studies appear to support its ef-
fect in homozygosity. Other associations currently
supported by moderate or strong evidence have all been
made since 2008.95% CI) p I2 (%) FE/RE
(1.16e1.40) 2.9  107 7.3 FE
(1.38e1.74) 1.2  1013 20.1 FE
(0.72e1.12) .34 66.5 RE
(0.50e0.90) 8.0  103 72.3 RE
(0.71e1.02) .08 48.7 RE
(0.49e0.91) 9.5  103 75.1 RE
(1.00e1.55) .047 53.0 RE
(1.13e1.84) 3.5  103 0.6 FE
(1.05e1.34) 5.0  103 45.6 RE
(1.05e1.37) 6.8  103 0.0 FE
(0.95e1.24) .24 50.1 RE
(0.36e4.94) .66 89.5 RE
(0.21e14.09) .61 41.2 RE
(0.91e2.77) .11 87.4 RE
(1.10e4.24) .03 84.0 RE
(0.68e2.30) .46 82.5 RE
(0.79e3.22) .19 74.3 RE
(0.46e1.14) .16 73.5 RE
(0.48e1.69) .74 77.9 RE
(0.25e5.85) .81 91.7 RE
(0.14e7.58) .97 76.4 RE
(0.89e1.78) .20 31.1 RE
(0.97e2.61) .06 53.7 RE
(0.45e1.93) .84 57.5 RE
(0.22e3.32) .81 87.8 RE
(1.00e1.19) .05 69.5 RE
(1.10e1.21) 2.5  1010 0.0 FE
(0.60e1.24) .43 73.7 RE
(0.46e0.93) .02 0 FE
(0.60e0.15) .25 70.9 RE
(0.70e1.02) .08 0.0 FE
(0.49e0.76) 1.6  105 0.0 FE
(0.92e1.18) .48 21.4 FE
(0.49e1.33) .41 35.4 RE
(0.91e1.27) .40 30.7 RE
(0.61e1.42) .75 0 FE
(0.90e1.29) .41 0.0 FE
(0.76e1.77) .48 50.7 RE
(0.87e1.30) .57 68.6 RE
(0.81e1.40) .66 60.7 RE
(0.85e1.36) .56 72.3 RE
(0.75e1.21) .70 37.1 RE
(0.84e1.55) .39 29.9 RE
Continued
Table 3-continued
Gene and polymorphism OR (95% CI) p I2 (%) FE/RE
NOS3 rs1799983 homozygous (T/T) 1.16 (0.52e2.58) .71 87.9 RE
PHACTR1 rs12526453 additive (C allele) 1.02 (0.86e1.22) .80 63.7 RE
SERPINE1 rs1799889 heterozygous (4G/5G) 0.90 (0.65e1.24) .51 0 FE
SERPINE1 rs1799889 homozygous (5G/5G) 1.10 (0.72e1.69) .66 0 FE
SERPINE1 rs1799889 heterozygous (4G/5G)a 0.92 (0.62e1.38) .62 0 FE
SERPINE1 rs1799889 homozygous (5G/5G)a 1.19 (0.70e2.03) .52 0 FE
SORT1 rs599839 additive (G Allele) 0.82 (0.77e0.86) 2.6  1013 0 FE
TGFBR2 rs1036095 heterozygous (C/G) 1.23 (0.83e1.81) .31 83.1 RE
TGFBR2 rs1036095 homozygous (G/G) 1.69 (0.76e3.77) .20 88.5 RE
TGFBR2 rs764522 heterozygous (C/G) 1.35 (0.91e1.99) .13 79.9 RE
TGFBR2 rs764522 homozygous (G/G) 1.73 (0.78e3.85) .18 86.2 RE
TRIB1 rs2954029 additive (A Allele) 1.06 (0.90e1.24) .45 59.0 RE
Note. OR ¼ odds ratio; CI ¼ conﬁdence interval; RE ¼ random effects meta-analysis; FE ¼ ﬁxed effects meta-analysis.
a Sensitivity analysis conducted with exclusion of studies because of deviation from HardyeWeinberg equilibrium or an extreme outlying
result.
70 D.T. Bradley et al.Interstudy inconsistency may be due to heterogeneity of
effect, systematic error, or bias. Multiple testing was usually
uncorrected and ﬂexible analysis was common: many
studies tested numerous inheritance models and subgroups,Table 4. Assessment of evidence of association.
Gene Polymorphism Amount of evidence R
3p21 rs7635818 A C
9p21 rs10757278 A A
ACE rs4646994 A A
AGTR1 rs5186 A B
APOA1 rs964184 A C
APOE rs439401 A C
APOB rs1367117 A C
CCR5 rs333 B C
CRP rs3091244 A C
DAB2IP rs7025486 A A
ELN rs2071307 B C
HLA-A A2 C C
HLA-B B61 C C
HMOX1 GT(n) C C
IL6R rs7529229 A A
IL10 rs1800896 B C
LDLR rs6511720 A B
LPA rs10455872 A A
LRP1 rs1466535 A A
MMP2 rs243865 B C
MMP3 rs3025058 A A
MMP9 rs3918242 B C
MMP13 rs2252070 C C
MTHFR1 rs1801133 B C
NOS3 rs1799983 B C
PLA2G7 rs16874954 B C
PHACTR1 rs12526453 A C
SERPINE1 rs1799889 A C
SORT1 rs599839 A A
TGFBR1 rs10819634
rs1571590
rs1626340
A C
TGFBR2 rs1036095
rs764522
A C
TIMP1 rs4898 C C
TIMP2 nt573 G/A C C
TRIB1 rs2954029 A Creporting signiﬁcance when p < .05. Several studies claimed
HWE, but deviated signiﬁcantly (p < .05).11,20
It is proposed herein that it may be time for the genetic
epidemiology research community to consider prospectiveeplication Protection from bias Overall assessment
C Weak
A Strong
C Weak
B Moderate
C Weak
C Weak
C Weak
C Weak
C Weak
A Strong
C Weak
C Weak
C Weak
C Weak
A Strong
B Weak
A Moderate
A Strong
A Strong
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B Moderate
C Weak
C Weak
C Weak
B Weak
C Weak
C Weak
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Abdominal Aortic Aneurysm Genetic Associations 71registration of aetiological studies to avoid ﬂexible post hoc
analyses. Simple standard steps, such as planning for
adequate power, using contemporaneous controls and
presenting counts and risk estimates for genotypes rather
than assuming models of inheritance, checking frequencies
in population databases, presenting analyses of HWE devi-
ation, and correcting for multiple testing would greatly
improve the quality of reports in this ﬁeld.
The present review excluded studies of aneurysm size or
growth, and did not attempt to integrate results for 27
associated polymorphisms that had been reported only once.
Supported associations suggest the importance of lipo-
proteins. LRP1, LDLR, SORT1, and the 9p21 locus affect
cholesterol metabolism and atherosclerosis. LRP1 has other
important regulatory roles, including regulation of extracel-
lular matrix breakdown by the endocytosis of proteinases.21
LPA produces lipoprotein A, which increases cardiovascular
risk.22 IL6R polymorphisms alter cardiovascular risk, possibly
through inﬂammation.23e26 MMP3 affects atherosclerosis
and tissue remodelling.27 Its association in this review is in
agreement with a recent meta-analysis.28 AGTR1 affects
blood pressure, which is consistent with the association
between hypertension and AAA.6,29 DAB2IP is a tumour-
suppressor gene involved in cell signalling, survival, migra-
tion, maturation, and apoptosis.13 Understanding their roles
may help develop prevention strategies based on under-
standing key biological pathways. Improving future study
design will avoid wasteful false associations.
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